Arcturus Therapeutics Holdings (ARCT) Net Cash Flow Growth (3y) (2021 - 2026)
Arcturus Therapeutics Holdings (ARCT) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 38.47% |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 166.26 Mn | -45.11 Mn | - | 32.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.81% |
| Dec 31, 2025 | -26.60% |
| Sep 30, 2025 | 29.42% |
| Jun 30, 2025 | 17.28% |
| Mar 31, 2025 | 26.62% |
| Dec 31, 2024 | 84.88% |
| Sep 30, 2024 | -9.31% |
| Jun 30, 2024 | 5.51% |
| Mar 31, 2024 | -42.85% |
| Dec 31, 2023 | -28.65% |
| Sep 30, 2023 | -27.40% |
| Jun 30, 2023 | -12.95% |
| Mar 31, 2023 | -75.22% |
| Dec 31, 2022 | 284.19% |
| Sep 30, 2022 | -65.08% |
| Jun 30, 2022 | -81.59% |
| Mar 31, 2022 | -109.97% |
| Dec 31, 2021 | -106.47% |
| Sep 30, 2021 | -169.48% |